Results 131 to 140 of about 34,480 (242)

Midterm Efficacy of SubcutAneous Implantable CardioVErter‐Defibrillator in ≤ 18 Year‐Old CHILDREN (SAVE CHILDREN‐II Registry)

open access: yesJournal of Arrhythmia, Volume 42, Issue 4, August 2026.
S‐ICD therapy demonstrated favorable mid‐term safety and efficacy in pediatric patients, with durable sensing performance and a low incidence of device‐related infection. ABSTRACT Background The subcutaneous implantable cardioverter‐defibrillator (S‐ICD) avoids transvenous leads and is a promising option for sudden cardiac death (SCD) prevention in ...
Hitoshi Mori   +76 more
wiley   +1 more source

Bisoprolol Treatment and Adherence in Pediatric Patients With Genotype‐Positive Long QT Syndrome

open access: yesJournal of Arrhythmia, Volume 42, Issue 4, August 2026.
LQTS is commonly treated with non‐selective beta‐blockers. In this study on Finnish pediatric patients with genotype positive LQTS1 or LQTS2, most with a Finnish founder mutation, the beta‐1‐selective bisoprolol was the most commonly used beta‐blocker with good adherence, effective heart rate control, and no cardiac events observed during follow‐up ...
Eemil Taipalus   +4 more
wiley   +1 more source

Modeling ventricular tachycardia in genetic long QT syndrome using engineered cardiac tissues. [PDF]

open access: yesBioact Mater
Zhuang RZ   +6 more
europepmc   +1 more source

Cardiovascular Diseases and Cancer: Convergent Proteostasis Networks at the Crossroads of Mechanisms and Therapeutic Opportunities

open access: yesMedComm, Volume 7, Issue 8, August 2026.
The disruption of proteostasis, encompassing the ubiquitin–proteasome system, autophagy, UPR/ER stress, and chaperone function, represents a fundamental mechanism shared by both cancer and cardiovascular diseases. While these pathways frequently facilitate tumor progression, they are crucial for maintaining proteostasis in cardiac tissue. Consequently,
Jacob Eli García Torres   +2 more
wiley   +1 more source

Perinatal management of congenital long QT syndrome: A case of maternal and fetal manifestations. [PDF]

open access: yesHeartRhythm Case Rep
da Silva Lopes M   +9 more
europepmc   +1 more source

Review of nutrition management of pediatric intestinal pseudo‐obstruction

open access: yesNutrition in Clinical Practice, Volume 41, Issue 4, Page 1048-1060, August 2026.
Abstract Chronic intestinal pseudo‐obstruction (CIPO) is a rare, heterogeneous, and debilitating disorder characterized by profound intestinal dysmotility and severe nutrition challenges. Its presentation resembles that of mechanical bowel obstruction, but CIPO occurs in the absence of luminal obstruction.
Senthilkumar Sankararaman   +5 more
wiley   +1 more source

Cross Sectional Study of Prenatal Diagnosis Uptake Among Individuals With Genetic Conditions

open access: yesPrenatal Diagnosis, Volume 46, Issue 9, Page 1374-1384, August 2026.
ABSTRACT Objective Prenatal diagnostic genetic testing allows for early identification of significant fetal conditions and enables informed decision‐making regarding management options. The aim of this study was to assess prenatal testing practice among individuals with genetic conditions.
Ebunoluwa Ojo   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy